Company Director at $KTOS sells 10,000 shares in insider transaction
shares for an estimated $980,595. Amy Zegart sold 10,000 shares for approximately $741,671, while Marie Mendoza, the SVP & General Counsel, sold 10,675 shares for around $679,044. De Burgreen Maria Cervantes, the VP & Corp. Controller, also made sales, with 6,264 shares for an estimated $437,202. This pattern of insider trading is not unique to $KTOS, as various executives and officers have engaged in similar sell-offs within the last 6 months.
Furthermore, institutional investors have also made significant moves regarding $KTOS stock in their portfolios. AllianceBernstein L.P. added over 2.5 million shares, a whopping 1389.0% increase, amounting to approximately $230,793,401. On the other hand, BAMCO INC/NY/ decided to remove 2,151,380 shares, a decrease of 52.7%, from their portfolio, valued at around $196,571,590. Other notable shifts include Price T Rowe Associates INC/MD adding 1,909,845 shares (+1315.2%), and BlackRock, INC. removing 1,801,350 shares (-6.9%). The fluctuations in institutional holdings reflect the dynamic nature of investors’ confidence in $KTOS and its future prospects.
Turning towards $KTOS’s financial performance, the company reported revenues of $347.6 million in Q3 2025, representing a significant 25.99% increase from the same period in the previous year. This growth suggests positive momentum and potentially promising outcomes for the company moving forward. $KTOS has also been under the scrutiny of Wall Street analysts, with 10 firms issuing buy ratings on the stock in recent months, indicating a favorable outlook on the company’s performance and potential growth.
Analysts have set various price targets for $KTOS, with a median target of $87.0 across 13 analysts in the last 6 months. Recent target prices have ranged from $95.0 to $125.0, demonstrating the varying expectations and valuations placed on $KTOS by different analysts and financial institutions. These price targets serve as benchmarks for investors and stakeholders to evaluate the company’s valuation and performance against market expectations.
In conclusion, the insider sale of 10,000 shares by Amy Zegart, along with other high-level executives’ sell-offs, institutional investors’ shifting positions, solid revenue growth, positive analyst ratings, and diverse price targets collectively contribute to a comprehensive picture of the ongoing activities and perceptions surrounding $KTOS. As always, investors should conduct their thorough research and due diligence before making any investment decisions.